• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 C-24 胆汁酸缀合物研究肠道胆汁酸转运蛋白的跨膜转运的结构决定因素。

Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.

机构信息

Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, 20 Penn Street, Baltimore, Maryland 21201, United States.

出版信息

Mol Pharm. 2010 Dec 6;7(6):2240-54. doi: 10.1021/mp100233v. Epub 2010 Nov 1.

DOI:10.1021/mp100233v
PMID:20939504
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2997912/
Abstract

The human apical sodium dependent bile acid transporter (hASBT) reabsorbs gram quantities of bile acid daily and is a potential prodrug target to increase oral drug absorption. In the absence of a high resolution hASBT crystal structure, 3D-QSAR modeling may prove beneficial in designing prodrug targets to hASBT. The objective was to derive a conformationally sampled pharmacophore 3D-QSAR (CSP-SAR) model for the uptake of bile acid conjugates by hASBT. A series of bile acid conjugates of glutamyl chenodeoxycholate were evaluated in terms of K(m) and normalized V(max) (normV(max)) using hASBT-MDCK cells. All monoanionic conjugates were potent substrates. Dianions, cations and zwitterions, which bound with a high affinity, were not substrates. CSP-SAR models were derived using structural and physicochemical descriptors, and evaluated via cross validation. The best CSP-SAR model for K(m) included two structural and two physiochemical descriptors, where substrate hydrophobicity enhanced affinity. A best CSP-SAR model for K(m)/normV(max) employed one structural and three physicochemical descriptors, also indicating hydrophobicity enhanced efficiency. Overall, the bile acid C-24 region accommodated a range of substituted anilines, provided a single negative charge was present near C-24. In comparing uptake findings to prior inhibition results, increased hydrophobicity enhanced activity, with dianions and zwitterions hindering activity.

摘要

人顶钠依赖性胆汁酸转运蛋白(hASBT)每天重吸收克数量的胆汁酸,是增加口服药物吸收的潜在前药靶点。由于缺乏高分辨率的 hASBT 晶体结构,3D-QSAR 建模可能有助于设计针对 hASBT 的前药靶标。本研究旨在为 hASBT 摄取胆汁酸缀合物推导构象采样药效团 3D-QSAR(CSP-SAR)模型。使用 hASBT-MDCK 细胞,以 K(m)和归一化 V(max)(normV(max))评估一系列谷氨酸鹅脱氧胆酸缀合物。所有单阴离子缀合物都是有效的底物。二阴离子、阳离子和两性离子,由于与高亲和力结合,不是底物。使用结构和物理化学描述符推导 CSP-SAR 模型,并通过交叉验证进行评估。用于 K(m)的最佳 CSP-SAR 模型包括两个结构和两个物理化学描述符,其中底物疏水性增强了亲和力。用于 K(m)/normV(max)的最佳 CSP-SAR 模型采用了一个结构和三个物理化学描述符,也表明疏水性增强了效率。总体而言,胆汁酸 C-24 区域可容纳一系列取代的苯胺,只要 C-24 附近存在一个单一的负电荷。将摄取发现与先前的抑制结果进行比较,疏水性增加可增强活性,二阴离子和两性离子则会阻碍活性。

相似文献

1
Structural determinants for transport across the intestinal bile acid transporter using C-24 bile acid conjugates.利用 C-24 胆汁酸缀合物研究肠道胆汁酸转运蛋白的跨膜转运的结构决定因素。
Mol Pharm. 2010 Dec 6;7(6):2240-54. doi: 10.1021/mp100233v. Epub 2010 Nov 1.
2
Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.使用谷氨酰 - 胆汁酸的氨基哌啶缀合物对人顶端钠依赖性胆汁酸转运体(hASBT)的抑制要求
Pharm Res. 2009 Jul;26(7):1665-78. doi: 10.1007/s11095-009-9877-3. Epub 2009 Apr 21.
3
Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporter.C-24区域电荷和空间位阻对胆汁酸与人顶端钠依赖性胆汁酸转运体相互作用的影响。
Mol Pharm. 2006 May-Jun;3(3):282-92. doi: 10.1021/mp0600135.
4
Structural requirements of the ASBT by 3D-QSAR analysis using aminopyridine conjugates of chenodeoxycholic acid.采用胆酸的氨基吡啶缀合物的 3D-QSAR 分析对 ASBT 的结构要求。
Bioconjug Chem. 2010 Nov 17;21(11):2038-48. doi: 10.1021/bc100273w. Epub 2010 Oct 22.
5
Synthesis and in vitro evaluation of gabapentin prodrugs that target the human apical sodium-dependent bile acid transporter (hASBT).合成并体外评价靶向人顶端钠依赖性胆酸转运体(hASBT)的加巴喷丁前药。
J Pharm Sci. 2011 Mar;100(3):1184-95. doi: 10.1002/jps.22332. Epub 2010 Sep 16.
6
Interaction of native bile acids with human apical sodium-dependent bile acid transporter (hASBT): influence of steroidal hydroxylation pattern and C-24 conjugation.天然胆汁酸与人顶端钠依赖性胆汁酸转运体(hASBT)的相互作用:甾体羟基化模式和C-24共轭的影响
Pharm Res. 2006 Jul;23(7):1451-9. doi: 10.1007/s11095-006-0219-4. Epub 2006 Jun 21.
7
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.分子开关控制阴离子胆汁酸缀合物与人顶侧钠依赖性胆汁酸转运蛋白的结合。
J Med Chem. 2010 Jun 24;53(12):4749-60. doi: 10.1021/jm1003683.
8
Structural requirements of the human sodium-dependent bile acid transporter (hASBT): role of 3- and 7-OH moieties on binding and translocation of bile acids.人钠依赖性胆汁酸转运体(hASBT)的结构要求:3-羟基和7-羟基部分在胆汁酸结合和转运中的作用
Mol Pharm. 2014 Feb 3;11(2):588-98. doi: 10.1021/mp400575t. Epub 2013 Dec 26.
9
Putative irreversible inhibitors of the human sodium-dependent bile acid transporter (hASBT; SLC10A2) support the role of transmembrane domain 7 in substrate binding/translocation.假定的人源钠依赖性胆酸转运蛋白(hASBT;SLC10A2)的不可逆抑制剂支持跨膜结构域 7 在底物结合/转运中的作用。
Pharm Res. 2012 Jul;29(7):1821-31. doi: 10.1007/s11095-012-0706-8. Epub 2012 Feb 22.
10
Development of stably transfected monolayer overexpressing the human apical sodium-dependent bile acid transporter (hASBT).稳定转染的过表达人顶端钠依赖性胆汁酸转运体(hASBT)的单层细胞的构建。
Pharm Res. 2005 Aug;22(8):1269-80. doi: 10.1007/s11095-005-5274-8. Epub 2005 Aug 3.

引用本文的文献

1
Novel nitroxide-bile acid conjugates inform substrate requirements for human bile acid transporters.新型氮氧自由基-胆酸缀合物为阐明人类胆酸转运蛋白的底物需求提供了信息。
Eur J Pharm Sci. 2023 Jan 1;180:106335. doi: 10.1016/j.ejps.2022.106335. Epub 2022 Nov 17.
2
Synthesis and Evaluation of Bile Acid-Ribavirin Conjugates as Prodrugs to Target the Liver.作为靶向肝脏的前药的胆汁酸-利巴韦林缀合物的合成与评价
J Pharm Sci. 2015 Sep;104(9):2864-76. doi: 10.1002/jps.24375. Epub 2015 Feb 2.
3
Mechanistic interpretation of conventional Michaelis-Menten parameters in a transporter system.转运体系统中传统米氏参数的机制性解释
Eur J Pharm Sci. 2014 Nov 20;64:44-52. doi: 10.1016/j.ejps.2014.08.007. Epub 2014 Aug 27.
4
In vivo effects of the pure aryl hydrocarbon receptor antagonist GNF-351 after oral administration are limited to the gastrointestinal tract.口服后,纯芳烃受体拮抗剂GNF-351的体内效应仅限于胃肠道。
Br J Pharmacol. 2014 Apr;171(7):1735-46. doi: 10.1111/bph.12576.
5
An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters.药物性胆汁淤积的最新研究进展:机制及理化性质和药代动力学参数研究。
J Pharm Sci. 2013 Sep;102(9):3037-57. doi: 10.1002/jps.23584. Epub 2013 May 7.
6
Design and characterization of a novel fluorinated magnetic resonance imaging agent for functional analysis of bile Acid transporter activity.新型氟代磁共振成像造影剂用于胆汁酸转运体活性的功能分析的设计与表征。
Pharm Res. 2013 May;30(5):1240-51. doi: 10.1007/s11095-012-0963-6. Epub 2013 Jan 15.
7
Automation of the CHARMM General Force Field (CGenFF) I: bond perception and atom typing.CHARMM 通用力场(CGenFF)的自动化 I:键的感知和原子类型化。
J Chem Inf Model. 2012 Dec 21;52(12):3144-54. doi: 10.1021/ci300363c. Epub 2012 Nov 28.
8
Computational modeling to accelerate the identification of substrates and inhibitors for transporters that affect drug disposition.用于加速鉴定影响药物处置的转运体底物和抑制剂的计算模型。
Clin Pharmacol Ther. 2012 Nov;92(5):661-5. doi: 10.1038/clpt.2012.164. Epub 2012 Sep 26.
9
Deconstructing 14-phenylpropyloxymetopon: minimal requirements for binding to mu opioid receptors.去构建 14-苯丙氧基甲氧基托啡诺:与μ阿片受体结合的最小要求。
Bioorg Med Chem. 2012 Jul 15;20(14):4556-63. doi: 10.1016/j.bmc.2012.05.006. Epub 2012 May 11.
10
Intrinsic energy landscapes of amino acid side-chains.氨基酸侧链的固有能量景观。
J Chem Inf Model. 2012 Jun 25;52(6):1559-72. doi: 10.1021/ci300079j. Epub 2012 May 24.

本文引用的文献

1
Molecular switch controlling the binding of anionic bile acid conjugates to human apical sodium-dependent bile acid transporter.分子开关控制阴离子胆汁酸缀合物与人顶侧钠依赖性胆汁酸转运蛋白的结合。
J Med Chem. 2010 Jun 24;53(12):4749-60. doi: 10.1021/jm1003683.
2
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields.CHARMM 通用力场:适用于 CHARMM 全原子加和生物力场的药物样分子力场。
J Comput Chem. 2010 Mar;31(4):671-90. doi: 10.1002/jcc.21367.
3
Bile acid transporters.胆汁酸转运体。
J Lipid Res. 2009 Dec;50(12):2340-57. doi: 10.1194/jlr.R900012-JLR200. Epub 2009 Jun 4.
4
CHARMM: the biomolecular simulation program.CHARMM:生物分子模拟程序。
J Comput Chem. 2009 Jul 30;30(10):1545-614. doi: 10.1002/jcc.21287.
5
Inhibition requirements of the human apical sodium-dependent bile acid transporter (hASBT) using aminopiperidine conjugates of glutamyl-bile acids.使用谷氨酰 - 胆汁酸的氨基哌啶缀合物对人顶端钠依赖性胆汁酸转运体(hASBT)的抑制要求
Pharm Res. 2009 Jul;26(7):1665-78. doi: 10.1007/s11095-009-9877-3. Epub 2009 Apr 21.
6
Method to screen substrates of apical sodium-dependent bile acid transporter.顶端钠依赖性胆汁酸转运体底物的筛选方法。
AAPS J. 2008 Dec;10(4):596-605. doi: 10.1208/s12248-008-9069-9. Epub 2008 Dec 16.
7
Computational model for predicting chemical substituent effects on passive drug permeability across parallel artificial membranes.用于预测化学取代基对药物经平行人工膜被动渗透影响的计算模型。
Mol Pharm. 2008 Sep-Oct;5(5):818-28. doi: 10.1021/mp800035h. Epub 2008 Aug 19.
8
Bile acid transporters: structure, function, regulation and pathophysiological implications.胆汁酸转运体:结构、功能、调节及病理生理学意义
Pharm Res. 2007 Oct;24(10):1803-23. doi: 10.1007/s11095-007-9289-1. Epub 2007 Apr 3.
9
Quantitative conformationally sampled pharmacophore for delta opioid ligands: reevaluation of hydrophobic moieties essential for biological activity.δ阿片样物质配体的定量构象采样药效团:对生物活性至关重要的疏水部分的重新评估
J Med Chem. 2007 Apr 19;50(8):1799-809. doi: 10.1021/jm0612463. Epub 2007 Mar 17.
10
Strong and weak hydrogen bonds in the protein-ligand interface.蛋白质-配体界面中的强氢键和弱氢键。
Proteins. 2007 Apr 1;67(1):128-141. doi: 10.1002/prot.21253.